Traynor Capital Management, Inc. Eli Lilly & CO Transaction History

Traynor Capital Management, Inc.

$1.6 Billion
Q3 2024

A detailed history of Traynor Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Traynor Capital Management, Inc. holds 48,032 shares of LLY stock, worth $37.4 Million. This represents 2.66% of its overall portfolio holdings.

Number of Shares

48,032

Previous 42,657 12.6%

Holding current value

$37.4 Million

Previous $38.6 Million 10.18%

% of portfolio

2.66%

Previous 2.95%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $4.15 Million - $5.16 Million	5,375 Added 12.6%	48,032 $42.6 Million
Q2 2024 Jul 24, 2024	BUY	$724.87 - $909.04 $8.57 Million - $10.7 Million	11,824 Added 38.35%	42,657 $38.6 Million
Q1 2024 Apr 12, 2024	BUY	$592.2 - $792.28 $5.07 Million - $6.78 Million	8,563 Added 38.45%	30,833 $24 Million
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $2.74 Million - $3.23 Million	5,212 Added 30.55%	22,270 $13 Million
Q3 2023 Oct 16, 2023	BUY	$434.7 - $599.3 $2.35 Million - $3.24 Million	5,398 Added 46.3%	17,058 $9.16 Million
Q2 2023 Jul 28, 2023	BUY	$350.74 - $468.98 $263,756 - $352,672	752 Added 6.89%	11,660 $5.47 Million
Q1 2023 Apr 21, 2023	BUY	$310.63 - $364.82 $846,466 - $994,134	2,725 Added 33.3%	10,908 $3.75 Million
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $1.93 Million - $2.25 Million	6,004 Added 275.54%	8,183 $0
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $2.25 Million - $2.57 Million	-7,604 Reduced 77.73%	2,179 $704,000
Q3 2022 Oct 20, 2022	BUY	$296.48 - $337.87 $2.49 Million - $2.84 Million	8,397 Added 605.84%	9,783 $3.16 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $6,968 - $8,181	-25 Reduced 1.77%	1,386 $449,000
Q1 2022 Apr 13, 2022	BUY	$234.69 - $291.66 $37,785 - $46,957	161 Added 12.88%	1,411 $404,000
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $11,242 - $13,952	50 Added 4.17%	1,250 $345,000
Q3 2021 Oct 25, 2021	BUY	$221.6 - $272.71 $265,920 - $327,252	1,200 New	1,200 $277,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Traynor Capital Management, Inc. with notifications on news.

Account

Traynor Capital Management, Inc. Eli Lilly & CO Transaction History